Lecanemab is the first novel treatment for Alzheimer's in more than 20 years Lecanemab, the disease-modifying drug which can slow down the progression of Alzheimer’s disease, is set to be one of the ...
For the first time, researchers described the structure of a special type of amyloid beta plaque protein associated with Alzheimer’s disease (AD) progression. In a report published May 10 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback